Cargando…
Radioimmunotherapy of micrometastases in lung with vascular targeted(213)Bi
A model system has been used to test the efficacy of vascular targeting of α-particle emitter(213)Bi for therapy of small, ‘artificial’ metastases in mouse lung. Specific monoclonal antibody (mAb) 201B was used to deliver greater than 30% of the injected dose to lung where tumours had developed due...
Autores principales: | Kennel, S J, Boll, R, Stabin, M, Schuller, H M, Mirzadeh, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362995/ https://www.ncbi.nlm.nih.gov/pubmed/10389994 http://dx.doi.org/10.1038/sj.bjc.6690337 |
Ejemplares similares
-
Radioimmunotherapy for Liver Micrometastases in Mice: Pharmacokinetics, Dose Estimation, and Long‐term Effect
por: Saga, Tsuneo, et al.
Publicado: (1999) -
Avidin Chase Can Reduce Myelotoxicity Associated with Radioimmunotherapy of Experimental Liver Micrometastases in Mice
por: Sato, Noriko, et al.
Publicado: (2000) -
α-Radioimmunotherapy with (213)Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myeloma
por: Teiluf, Katharina, et al.
Publicado: (2014) -
Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the (213)Bi-labeled monoclonal antibody MX35 in an ovarian cancer model
por: Gustafsson-Lutz, Anna, et al.
Publicado: (2017) -
Level structure in $^{213}Bi$
por: Chumin, V G, et al.
Publicado: (1996)